This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Risen (Suzhou) Pharma Tech Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Chuanhao Huang: Innovator in CD73 Inhibitors
Introduction
Chuanhao Huang is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of CD73 inhibitors. His work focuses on innovative solutions for treating diseases associated with CD73.
Latest Patents
Chuanhao Huang holds a patent for "CD73 inhibitors and pharmaceutical uses thereof." This patent includes compounds that inhibit CD73, also known as ecto-5′-nucleotidase. The compounds are designed for treating or preventing CD73-associated diseases, disorders, and conditions, including cancer and immune-related disorders. The patent outlines various structures of CD73 inhibitor compounds, including pharmaceutically acceptable esters or salts.
Career Highlights
Chuanhao Huang is currently employed at Risen (Suzhou) Pharma Tech Co., Ltd. His role at the company allows him to further his research and development efforts in the pharmaceutical industry. With a focus on innovative treatments, he has established himself as a key figure in his field.
Collaborations
Chuanhao Huang collaborates with notable colleagues, including Qiguo Zhang and Gang Chen. Their combined expertise contributes to the advancement of research and development in pharmaceutical applications.
Conclusion
Chuanhao Huang's work in CD73 inhibitors represents a significant advancement in the treatment of various diseases. His innovative approach and dedication to research continue to impact the pharmaceutical industry positively.